AIM IMMUNOTECH INC. Payments to Acquire Investments
AIM IMMUNOTECH INC. (AIM) reported Payments to Acquire Investments of $6.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInvestments · last filed 2026-08-07
- AIM IMMUNOTECH INC. payments to acquire investments for the quarter ending 2026-06-30 was $0.00.
- AIM IMMUNOTECH INC. payments to acquire investments for the quarter ending 2026-03-31 was $6.00K, a 93.41% decline year-over-year.
- AIM IMMUNOTECH INC. payments to acquire investments for the quarter ending 2025-06-30 was $0.00.
- AIM IMMUNOTECH INC. payments to acquire investments for the quarter ending 2025-03-31 was $91.00K, a 42.41% decline year-over-year.
- AIM IMMUNOTECH INC. payments to acquire investments for fiscal 2024 was $361.00K, a 77.34% decline from fiscal 2023.
- AIM IMMUNOTECH INC. payments to acquire investments for fiscal 2023 was $1.59M, a 41.52% decline from fiscal 2022.
- AIM IMMUNOTECH INC. payments to acquire investments for fiscal 2022 was $2.72M.
| Period end | Payments to Acquire Investments 3 month | Payments to Acquire Investments 6 month | Payments to Acquire Investments 9 month | Payments to Acquire Investments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $6.00K 10-Q · filed 2026-08-07 | ||
| 2026-03-31 | $6.00K 10-Q · filed 2026-05-15 | |||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $91.00K 10-Q · filed 2026-08-07 | $294.00K derived: sum of 3 quarters · filed 2026-08-07 | $294.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $91.00K 10-Q · filed 2026-05-15 | $294.00K derived: sum of 2 quarters · filed 2026-05-15 | $294.00K derived: sum of 3 quarters · filed 2026-05-15 | $294.00K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $203.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $203.00K derived: sum of 2 quarters · filed 2025-03-27 | $203.00K derived: sum of 3 quarters · filed 2025-03-27 | $361.00K 10-K · filed 2025-03-27 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $0.00 derived: sum of 2 quarters · filed 2024-11-14 | $158.00K 10-Q · filed 2024-11-14 | $596.00K derived: sum of 4 quarters · filed 2025-03-27 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $158.00K 10-Q · filed 2024-08-14 | $596.00K derived: sum of 3 quarters · filed 2025-03-27 | $1.04M derived: sum of 4 quarters · filed 2025-03-27 |
| 2024-03-31 | $158.00K 10-Q · filed 2024-05-15 | $596.00K derived: sum of 2 quarters · filed 2025-03-27 | $1.04M derived: sum of 3 quarters · filed 2025-03-27 | $1.04M derived: sum of 4 quarters · filed 2025-03-27 |
| 2023-12-31 | $438.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $881.00K derived: sum of 2 quarters · filed 2025-03-27 | $881.00K derived: sum of 3 quarters · filed 2025-03-27 | $1.59M 10-K · filed 2025-03-27 |
| 2023-09-30 | $443.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $443.00K derived: sum of 2 quarters · filed 2024-11-14 | $1.16M 10-Q · filed 2024-11-14 | $2.22M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $712.00K 10-Q · filed 2024-08-14 | $1.77M derived: sum of 3 quarters · filed 2024-08-14 | |
| 2023-03-31 | $712.00K 10-Q · filed 2024-05-15 | $1.77M derived: sum of 2 quarters · filed 2024-05-15 | ||
| 2022-12-31 | $1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $2.72M 10-K · filed 2024-04-01 | ||
| 2022-09-30 | $1.66M 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |